Zydus Lifesciences gets FDA final approval for Varenicline Tablets

Pallavi Madhiraju- June 18, 2023 0

Zydus Lifesciences has been granted final approval from the US Food and Drug Administration (FDA) to manufacture and market Varenicline Tablets, 0.5 mg and 1 ... Read More

Zydus Lifesciences’ Diclofenac Sodium and Misoprostol Tablets gets FDA final approval

Pallavi Madhiraju- June 18, 2023 0

Zydus Lifesciences has secured final approval from the US Food and Drug Administration (FDA) to manufacture and market Diclofenac Sodium and Misoprostol Delayed Release Tablets ... Read More

Granules India gets FDA approval for generic epilepsy drug Levetiracetam

Pallavi Madhiraju- June 16, 2023 0

Granules India has announced its receipt of approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam ... Read More

Natco Pharma wins FDA approval for generic colorectal cancer drug

Pallavi Madhiraju- June 16, 2023 0

Indian pharmaceutical firm Natco Pharma has gained the US Food and Drug Administration (FDA)'s final approval for its abbreviated new drug application (ANDA) for Tipiracil ... Read More

Zydus Lifesciences’ Ahmedabad plant passes FDA inspection with no observations

Pallavi Madhiraju- June 14, 2023 0

AHMEDABAD, INDIA - Indian lifesciences company, Zydus Lifesciences, announced on Tuesday that its injectables manufacturing facility at Zydus Biotech Park in Changodar, Ahmedabad has passed ... Read More

Ipsen gets Bylvay FDA approval for cholestatic pruritus in Alagille syndrome

Pallavi Madhiraju- June 13, 2023 0

The US Food and Drug Administration (FDA) has granted approval to French biopharmaceutical company Ipsen for Bylvay (odevixibat) for the treatment of cholestatic pruritus in ... Read More

FDA greenlights Granules India’s Metoprolol Succinate ER tablets

Pallavi Madhiraju- June 13, 2023 0

Granules India Limited announced its receipt of US Food and Drug Administration (FDA) approval for its Abbreviated New Drug Application (ANDA) of Metoprolol Succinate Extended-Release ... Read More

Caplin Point to tap into $35m market after FDA approval for NIMBEX generic

Pallavi Madhiraju- June 13, 2023 0

Caplin Steriles, a subsidiary of India's Caplin Point Laboratories, has obtained final approval from the US Food and Drug Administration (FDA) for its generic version ... Read More

AVATAR MEDICAL virtual reality surgical planning solution gets FDA clearance

Pallavi Madhiraju- June 6, 2023 0

French medtech startup AVATAR MEDICAL announced that its virtual reality (VR) surgical planning solution has received 510(k) clearance from the US Food and Drug Administration ... Read More

Lupin obtains FDA approval for generic version of Ocaliva Tablets

Pallavi Madhiraju- June 3, 2023 0

Indian pharmaceutical company Lupin has announced its approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for Obeticholic ... Read More